Front Row Advisors LLC
- SEC CIK
- 0001729254
- Latest filing
- Aug 13, 2026
ITCI holding history
Intra-Cellular Therapies, Inc. in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITCI overviewAll 13F holders of ITCIFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −97−100.0% | Sold out | Holders |
| Q2 2024 | 97 | $6.64K | <0.1% | −36−27.1% | Reduced | Holders |
| Q1 2024 | 133 | $9.20K | <0.1% | +133 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −117−100.0% | Sold out | Holders |
| Q3 2023 | 117 | $6.09K | <0.1% | +9+8.3% | Added | Holders |
| Q2 2023 | 108 | $7.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 108 | $6.00K | <0.1% | +23+27.1% | Added | Holders |
| Q4 2022 | 85 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 85 | $4.00K | <0.1% | +85 | New | Holders |